MAXYVAX Trademark

Trademark Overview


On Wednesday, July 21, 1999, a trademark application was filed for MAXYVAX with the United States Patent and Trademark Office. The USPTO has given the MAXYVAX trademark a serial number of 75756459. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, June 13, 2003. This trademark is owned by Maxygen, Inc.. The MAXYVAX trademark is filed in the Pharmaceutical Products category with the following description:

vaccines and adjuvants for vaccines for human use

General Information


Serial Number75756459
Word MarkMAXYVAX
Filing DateWednesday, July 21, 1999
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, June 13, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesvaccines and adjuvants for vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 4, 1999
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMaxygen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063

Trademark Events


Event DateEvent Description
Friday, June 13, 2003ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, October 28, 2002NON-FINAL ACTION MAILED
Monday, August 28, 2000LETTER OF SUSPENSION MAILED
Thursday, April 27, 2000CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 9, 1999NON-FINAL ACTION MAILED
Thursday, October 28, 1999ASSIGNED TO EXAMINER

Related Keywords


maxyvax vaccines human adjuvants